Cargando…
Coronavirus disease 2019 vaccine: An overview of the progression and current use
On December 31, 2019; unidentified pneumonia cases were reported from China. It was soon announced that these cases were of viral origin and the cause was a new coronavirus (CoV). Initially, the virus was called “novel CoV “ and then defined as “severe acute respiratory syndrome CoV 2 (SARS-CoV-2)”...
Autores principales: | Gocer, Safiye, Turk, Can, Ozguven, Sukru Volkan, Doganay, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630730/ https://www.ncbi.nlm.nih.gov/pubmed/34909595 http://dx.doi.org/10.14744/nci.2021.99075 |
Ejemplares similares
-
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
por: Alagheband Bahrami, Armina, et al.
Publicado: (2022) -
New threat: 2019 novel Coronavirus infection and infection control perspective in Turkey
por: Kilic, Aysegul Ulu, et al.
Publicado: (2020) -
Coronavirus disease–2019 and the intestinal tract: An overview
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2021) -
Coronavirus disease 2019: scientific overview of the global pandemic
por: Dey, A., et al.
Publicado: (2020) -
Overview of coronavirus disease 2019: Treatment updates and advances
por: Luo, Yung-Hung, et al.
Publicado: (2020)